ghk-cu clinical trial wound healing randomized Food-Derived Tripeptide–Copper Self-Healing Hydrogel for Infected GHK-Cu | Copper Tripeptide Purity
Description
Gene expression
Standard research protocols use 1.6 mg administered subcutaneously, typically twice weekly
This compound is strictly intended for research use only (RUO) and is not approved for human medical or therapeutic use
Recovery Blends Stack-style product presentation for customers comparing combined recovery peptide formats
Our complete list of injectable peptides covers the full range of compounds commonly delivered this way
This individualized approach ensures you feel informed, supported, and confident moving forward
